Dupilumab an Option When Other Targeted Agents Fail in Aspirin-Exacerbated Respiratory Disease
03/08/2021

Dupilumab an Option When Other Targeted Agents Fail in Aspirin-Exacerbated Respiratory Disease

NEW YORK (Reuters Health) – Dupilumab, a monoclonal antibody targeting interleukin-4 (IL-4) re...
read more